Shilpa Biologicals Partners with Mabtree Biologics for New Biological Entity

Shilpa Biologicals, a subsidiary of Shilpa Medicare, has entered into a binding term sheet with Mabtree Biologics AG. The agreement outlines the development, manufacture, marketing, and sale of a new biological entity. This strategic partnership underscores Shilpa Medicare's commitment to expanding its biologics portfolio and enhancing its global presence in the pharmaceutical sector. Shilpa Medicare has been actively participating in global events to foster collaborations and leverage its capabilities in biologics and CDMO services.

 

Sources: NSE, BSE, Shilpa Medicare